Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Modalis Therapeutics Corporation ( (JP:4883) ) has provided an update.
Modalis Therapeutics Corporation has completed the pay-in procedures for issuing new shares as part of a restricted-stock-based remuneration plan for its subsidiary employees. This issuance involves 2,300 common shares at a price of 75 yen per share, reflecting the company’s commitment to incentivizing its workforce and potentially enhancing its operational efficiency.
More about Modalis Therapeutics Corporation
Modalis Therapeutics Corporation is a biotechnology company listed on the Tokyo Stock Exchange, focused on developing innovative therapeutic solutions. The company specializes in gene therapy technologies and aims to address unmet medical needs in the healthcare industry.
Average Trading Volume: 1,710,715
Technical Sentiment Signal: Sell
Current Market Cap: Yen5.69B
For detailed information about 4883 stock, go to TipRanks’ Stock Analysis page.